Small molecule sAPPalpha enhancers that inhibit brain p-Tau as a therapeutic for Alzheimer’s Disease (UCLA Case No. 2025-163)

For More Information: Earl Weinstein Associate Director of Business Development eweinstein@tdg.ucla.edu